BX-048, a major active metabolite of BX 667, is a novel and potent antagonist of P2Y12 adenosine diphosphate receptor which inhibits platelet aggregation. It is a potential antiplatelet therapeutic agent which blocks ADP-induced platelet aggregation in human, dog and rat blood with IC50 of 97, 317 and 3000 nM respectively.

纯度：≥98%

CAS：937395-09-0